GO:2000798 negative regulation of amniotic stem cell differentiation: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000798 describes any process that stops, prevents, or reduces the frequency, rate, or extent of amniotic stem cell differentiation.
• Amniotic stem cells, including amniotic epithelial and amniotic fluid-derived stem cells, are multipotent and can differentiate into multiple lineages such as islet-like cells, osteogenic cells, and germ-like cells [1, 2, 4].
• Negative regulation of amniotic stem cell differentiation is critical for maintaining a stem cell reservoir and preventing premature lineage commitment [3, 5].
• Key molecular players include microRNAs (e.g., miR-32), methylation-dependent gene silencing, and signaling proteins such as tuberin and PRAS40 [3, 5, 7].
• Dysregulation of this process is linked to developmental anomalies, impaired tissue regeneration, and diseases such as diabetes and fetal malformations [3, 8].
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of the regulatory networks controlling amniotic stem cell differentiation [1, 4, 8].
Description
Amniotic stem cells are a promising source for regenerative medicine because they are multipotent, easily isolated, and ethically uncontroversial [1, 6]. The Gene Ontology term GO:2000798, negative regulation of amniotic stem cell differentiation, refers to any biological process that stops, prevents, or reduces the frequency, rate, or extent of amniotic stem cell differentiation. Understanding this process is essential for controlling stem cell fate and harnessing their therapeutic potential [3, 5].
negative regulation of amniotic stem cell differentiation At A Glance
| GO ID | GO:2000798 |
|---|---|
| GO term | negative regulation of amniotic stem cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Maintenance of amniotic stem cell pluripotency/multipotency by inhibiting differentiation |
| Related cell types | Amniotic epithelial stem cells, amniotic fluid stem cells |
| Key regulators | MicroRNAs, epigenetic modifiers, signaling proteins (e.g., tuberin, PRAS40) |
| Disease relevance | Developmental anomalies, diabetes, impaired regeneration |
What Is GO:2000798?
GO:2000798 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of amniotic stem cell differentiation. In other words, it encompasses molecular mechanisms that actively keep amniotic stem cells in an undifferentiated, multipotent state or delay their commitment to specific lineages [1, 3].
Why Is negative regulation of amniotic stem cell differentiation Important in Cell Biology?
Negative regulation of amniotic stem cell differentiation is vital for preserving the stem cell pool and preventing premature differentiation, which can lead to developmental defects or loss of regenerative capacity [3, 5]. Manipulating this process could enhance stem cell-based therapies for diabetes, bone defects, and other conditions [3, 8].
• Maintains the undifferentiated state of amniotic stem cells for therapeutic applications.
• Prevents premature differentiation that may cause fetal anomalies.
• Regulates differentiation into insulin-producing islet-like cells, relevant to diabetes [3, 7].
• Involves epigenetic mechanisms such as DNA methylation that silence differentiation genes.
• Modulated by microRNAs that target pluripotency factors.
• Influenced by anti-apoptotic proteins like tuberin and PRAS40 during early differentiation.
• Critical for germ cell formation and reproductive toxicity studies.
• Provides a model to study gene mutations and toxicant effects on stem cell fate.
• Potential target for enhancing bone regeneration via osteogenic differentiation control.
• Offers insights into stem cell quiescence and activation in regenerative medicine.
What Happens During negative regulation of amniotic stem cell differentiation?
Maintenance of pluripotency networks
In simple terms: Cells keep their stem cell identity by activating genes that block differentiation.
Amniotic stem cells express pluripotency-associated factors that actively repress differentiation programs. MicroRNA-32, for example, silences WWP2 to maintain pluripotency of human amniotic epithelial stem cells. This regulation ensures that cells remain multipotent and ready for controlled differentiation.
Epigenetic silencing of differentiation genes
In simple terms: Chemical tags on DNA can turn off genes that would otherwise cause cells to specialize.
DNA methylation changes are involved in the differentiation of human amniotic epithelial cells into islet-like cell clusters. Negative regulation often involves methylation-mediated silencing of pro-differentiation genes, thereby preventing premature lineage commitment.
Signaling pathways that inhibit differentiation
In simple terms: Signals from inside or outside the cell can put the brakes on specialization.
Tuberin and PRAS40 act as anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation. Their activity helps balance survival and differentiation cues, contributing to negative regulation of differentiation under certain conditions.
MicroRNA-mediated repression
In simple terms: Small RNA molecules can block the production of proteins that drive differentiation.
MicroRNAs such as miR-32 post-transcriptionally repress targets that promote differentiation, thereby maintaining stemness. This layer of regulation allows rapid and reversible control of differentiation in response to environmental signals.
Key Genes Involved in GO:2000798 negative regulation of amniotic stem cell differentiation
The following genes and proteins have been experimentally linked to the regulation of amniotic stem cell differentiation and are key candidates for studying GO:2000798.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WWP2 | E3 ubiquitin-protein ligase; target of miR-32 | Silenced by miR-32 to maintain pluripotency |
| MIR32 | MicroRNA that silences WWP2 | Maintains pluripotency of human amniotic epithelial stem cells |
| TSC2 (Tuberin) | GTPase-activating protein; anti-apoptotic | Gatekeeper during early amniotic fluid stem-cell differentiation |
| AKT1S1 (PRAS40) | mTORC1 inhibitor; anti-apoptotic | Gatekeeper during early amniotic fluid stem-cell differentiation |
| WDR35 | Intraflagellar transport protein | Down-regulation linked to fetal anomaly via osteogenic differentiation |
| DNMTs | DNA methyltransferases | Mediate methylation changes during islet-like differentiation |
| OCT4 (POU5F1) | Pluripotency transcription factor | Maintains stemness; down-regulation initiates differentiation |
| SOX2 | Pluripotency transcription factor | Maintains stemness; down-regulation initiates differentiation |
| NANOG | Pluripotency transcription factor | Maintains stemness; down-regulation initiates differentiation |
| NES | Intermediate filament protein | Marker of neural differentiation; its suppression indicates negative regulation |
| VIM | Intermediate filament protein | Marker of mesenchymal differentiation; its suppression indicates negative regulation |
| CD44 | Cell surface glycoprotein | Marker of mesenchymal stem cells; expression changes during differentiation |
| CD105 (ENG) | Cell surface protein | Marker of mesenchymal stem cells; expression changes during differentiation |
| CYP1A1 | Cytochrome P450 enzyme | Used in toxicant studies on germ cell formation |
| DAZL | RNA-binding protein | Germ cell marker; differentiation effects studied in amniotic fluid stem cell models |
| VASA (DDX4) | DEAD-box helicase | Germ cell marker; differentiation effects studied in amniotic fluid stem cell models |
| INS | Insulin | Marker of islet-like cell differentiation [3, 7] |
| PDX1 | Pancreatic transcription factor | Marker of islet-like cell differentiation [3, 7] |
How Is negative regulation of amniotic stem cell differentiation Regulated?
Negative regulation of amniotic stem cell differentiation is controlled by a network of microRNAs, epigenetic modifiers, and signaling proteins. For instance, miR-32 silences WWP2 to maintain pluripotency, while DNA methylation changes silence pro-differentiation genes during islet-like differentiation. Tuberin and PRAS40 act as anti-apoptotic gatekeepers that influence early differentiation decisions. These regulators ensure that differentiation is tightly controlled in response to developmental and environmental cues.
negative regulation of amniotic stem cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WDR35 | Fetal anomaly, skeletal dysplasia | Knockout or knockdown in amniotic stem cells followed by osteogenic differentiation |
| MIR32 | Diabetes, islet dysfunction | Overexpression or knockout of miR-32 in human amniotic epithelial stem cells |
| WWP2 | Pluripotency maintenance, cancer | Point mutation or knockout to study ubiquitination in stemness |
| TSC2 | Tuberous sclerosis, apoptosis | Knockout in amniotic fluid stem cells to assess differentiation and survival |
| AKT1S1 | mTOR-related disorders | Knockout or knock-in to study PRAS40 function in differentiation |
Developmental anomalies
Down-regulation of WDR35 contributes to fetal anomaly via dysregulation of osteogenic differentiation. This suggests that improper negative regulation of amniotic stem cell differentiation can lead to skeletal and developmental defects.
Diabetes and islet regeneration
Amniotic epithelial stem cells can differentiate into islet-like cell clusters, and microRNA-32-mediated maintenance of pluripotency affects this process [3, 7]. Defects in negative regulation may impair the ability to generate insulin-producing cells, relevant to diabetes therapy.
Reproductive toxicity and germ cell formation
Amniotic fluid stem cell-based models are used to study the effects of gene mutations and toxicants on male germ cell formation. Negative regulation of differentiation is critical for proper germ cell development and may be disrupted by environmental toxicants.
From negative regulation of amniotic stem cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate amniotic stem cell differentiation? | CRISPR knockout of gene X in amniotic stem cells followed by differentiation assays [1, 4] |
| Does a specific point mutation in gene Y affect its regulatory function? | CRISPR point mutation knock-in in amniotic stem cells [3, 5] |
| Does overexpression of gene Z inhibit differentiation? | CRISPR-mediated overexpression or lentiviral overexpression in amniotic stem cells [3, 7] |
| How does epigenetic silencing of gene W affect differentiation? | CRISPR knockout of DNA methyltransferases or epigenetic editors |
| What is the role of microRNA M in maintaining pluripotency? | Knockout or overexpression of microRNA M in amniotic stem cells |
| Can toxicants disrupt negative regulation of differentiation? | Amniotic fluid stem cell-based models exposed to toxicants |
How to Study the negative regulation of amniotic stem cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify differentiation markers and regulatory pathways [3, 7] |
| qPCR | Expression of specific genes/miRNAs | Validate differentiation and pluripotency markers [3, 4] |
| Bisulfite sequencing | DNA methylation status | Assess epigenetic silencing of differentiation genes |
| Western blot | Protein expression and phosphorylation | Measure signaling proteins like tuberin, PRAS40 |
| Immunofluorescence | Protein localization and marker expression | Confirm differentiation status in situ |
| Luciferase reporter assay | MicroRNA target validation | Confirm miR-32 targeting of WWP2 |
| CRISPR knockout screening | Gene function on a genome-wide scale | Identify novel negative regulators of differentiation [1, 8] |
| Flow cytometry | Cell surface marker expression | Sort differentiated vs. undifferentiated cells |
Differentiation assays
In vitro differentiation assays using specific induction media (e.g., osteogenic, adipogenic, islet-like) are used to measure the rate and extent of differentiation. Markers such as insulin, PDX1, osteocalcin, and others are quantified by qPCR or immunofluorescence [3, 4, 7].
Epigenetic profiling
DNA methylation analysis (e.g., bisulfite sequencing) and chromatin immunoprecipitation (ChIP) can reveal epigenetic changes that silence or activate differentiation genes during negative regulation.
MicroRNA and gene expression analysis
RNA-seq and qPCR are used to measure microRNA and mRNA levels. Luciferase reporter assays validate microRNA targets, such as miR-32 targeting WWP2.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify novel regulators of amniotic stem cell differentiation. These screens couple guide RNAs with differentiation readouts to uncover genes that negatively regulate differentiation [1, 8].
How CRISPR Can Be Used to Study GO:2000798 negative regulation of amniotic stem cell differentiation
Knockout
CRISPR knockout of candidate genes (e.g., WWP2, TSC2) in amniotic stem cells can reveal whether they are required for negative regulation of differentiation. Loss-of-function studies followed by differentiation assays quantify changes in lineage commitment [1, 3, 5].
Point Mutation
Introducing specific point mutations (e.g., in TSC2 or AKT1S1) via CRISPR base editing or HDR allows precise dissection of phosphorylation sites or catalytic residues involved in negative regulation.
Knock-in
Knock-in of reporter genes (e.g., fluorescent proteins) or epitope tags at endogenous loci enables live tracking of differentiation markers and protein localization in amniotic stem cells [4, 7].
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of microRNAs (e.g., miR-32) or genes (e.g., WDR35) can test whether increased dosage enhances negative regulation of differentiation [3, 8].
How EDITGENE Supports negative regulation of amniotic stem cell differentiation Research
Researchers studying negative regulation of amniotic stem cell differentiation-related genes often need to determine whether a candidate gene is causally involved in maintaining stemness or preventing differentiation. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of amniotic stem cell differentiation research.
Frequently Asked Questions About negative regulation of amniotic stem cell differentiation
What is GO:2000798?
GO:2000798 is the Gene Ontology term for negative regulation of amniotic stem cell differentiation, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of amniotic stem cell differentiation.
What genes are involved in negative regulation of amniotic stem cell differentiation?
Key genes include WWP2, MIR32, TSC2, AKT1S1, WDR35, and pluripotency factors like OCT4, SOX2, and NANOG [1, 3, 5, 8].
How is amniotic stem cell differentiation regulated?
It is regulated by microRNAs (e.g., miR-32), epigenetic modifications (e.g., DNA methylation), and signaling proteins such as tuberin and PRAS40 [3, 5, 7].
Why is negative regulation of amniotic stem cell differentiation important?
It maintains the stem cell pool and prevents premature differentiation, which is crucial for development and regenerative therapies [3, 5].
What diseases are linked to dysregulation of amniotic stem cell differentiation?
Dysregulation is linked to fetal anomalies, diabetes, and reproductive toxicity [2, 3, 8].
What research methods are used to study GO:2000798?
Methods include differentiation assays, RNA-seq, bisulfite sequencing, CRISPR screens, and luciferase reporter assays [1, 3, 7].
Can CRISPR be used to study negative regulation of amniotic stem cell differentiation?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are powerful tools to dissect this process [1, 3, 5].
What are amniotic stem cells?
Amniotic stem cells are multipotent cells derived from the amniotic membrane or amniotic fluid, capable of differentiating into multiple lineages [1, 4].
How does miR-32 regulate amniotic stem cell differentiation?
miR-32 silences WWP2 expression to maintain pluripotency and inhibit differentiation of human amniotic epithelial stem cells.
What is the role of WDR35 in amniotic stem cell differentiation?
Down-regulation of WDR35 contributes to fetal anomaly via dysregulation of osteogenic differentiation.
Conclusion
GO:2000798, negative regulation of amniotic stem cell differentiation, is a critical biological process that safeguards stemness and prevents premature lineage commitment. Understanding its molecular players and regulatory mechanisms offers insights into developmental biology and disease, and opens avenues for regenerative medicine. EDITGENE's CRISPR services provide robust tools to investigate this process and accelerate therapeutic development.
References
- 1. Koike C et al.. 2014. Characterization of amniotic stem cells.. Cell Reprogram 16(4):298-305 PMID: 25068631
- 2. Gundacker C et al.. 2012. Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.. Asian J Androl 14(2):247-50 PMID: 22231297
- 3. Zou G et al.. 2018. MicroRNA‑32 silences WWP2 expression to maintain the pluripotency of human amniotic epithelial stem cells and β islet‑like cell differentiation.. Int J Mol Med 41(4):1983-1991 PMID: 29393344
- 4. Marcus AJ et al.. 2008. Isolation, characterization, and differentiation of stem cells derived from the rat amniotic membrane.. Differentiation 76(2):130-44 PMID: 17608732
- 5. Fuchs C et al.. 2012. Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation.. Hum Mol Genet 21(5):1049-61 PMID: 22090422
- 6. Saxena AK et al.. 2010. Role of stem cell research in therapeutic purpose--a hope for new horizon in medical biotechnology.. J Exp Ther Oncol 8(3):223-33 PMID: 20734921
- 7. Peng L et al.. 2014. Involvement of gene methylation changes in the differentiation of human amniotic epithelial cells into islet-like cell clusters.. DNA Cell Biol 33(9):591-8 PMID: 24945458
- 8. Hu Z et al.. 2019. Down-regulated WDR35 contributes to fetal anomaly via regulation of osteogenic differentiation.. Gene 697:48-56 PMID: 30790652
